Trial Profile
A retrospective study of Bortezomib in patients with Multiple Myeloma
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 12 Sep 2016
Price :
$35
*
At a glance
- Drugs Bortezomib (Primary)
- Indications Multiple myeloma
- Focus Adverse reactions; Therapeutic Use
- 12 Sep 2016 New trial record